Faculty

Share
Share
and/or
27 Faculty members found
Human Oncology & Pathogenesis Program
Chi Lab
Ping Chi, MD, PhD
Physician-scientist Ping Chi studies genetic and epigenetic mechanisms of transcriptional regulation by oncogenic factors in GIST, MPNST, melanoma and other solid tumors.
Human Oncology & Pathogenesis Program
The Piro Lito Lab
Piro Lito, MD, PhD
Physician-scientist Piro Lito studies oncoproteins that drive cancer cell growth.
Human Oncology & Pathogenesis Program
Rachel Niec, MD, PhD
Physician-scientist Rachel Niec studies how cells and tissues communicate to promote health or drive inflammation and cancer.
Human Oncology & Pathogenesis Program
The Levine Lab
Ross L. Levine, MD
Mechanisms of genetic and epigenetic cooperativity which drive myeloid transformation; Elucidating and modeling evolution from hematopoietic stem/progenitor cells to clonal hematopoiesis and then to myeloid malignancies; Identification and credentialing novel therapeutic dependencies in myeloid malignancies
Memorial Hospital Research Laboratories
Samuel Singer, MD, FACS
Physician-scientist Samuel Singer studies the genomic alterations that define new targets for therapy in sarcoma. I am a surgical oncologist who specializes in the diagnosis and treatment of soft tissue sarcoma. I have extensive experience with this group of cancers, and am one of just a few surgeons in the world focused solely on treating sarcoma patients. My years of experience have enabled me to devise surgical techniques that improve the ability to completely remove these tumors. In addition to my clinical sarcoma practice, I conduct laboratory research to develop new methods to improve the diagnosis and treatment of sarcoma. I lead both a National Cancer Institute Specialized Program in Research Excellence (SPORE) and the Sarcoma Genome Project.
Human Oncology & Pathogenesis Program
Chandarlapaty Lab
Sarat Chandarlapaty, MD, PhD
Physician-scientist Sarat Chandarlapaty studies the regulation of growth factor signaling networks in cancer.
Human Oncology & Pathogenesis Program
The Chen Lab
Yu Chen, MD, PhD
Physician-scientist Yu Chen studies the role of transcription factors that are critical for prostate cancer development.